News

Developed to treat adult patients with major depressive episodes associated with bipolar I disorder, Latuda has been approved for use as monotherapy and as adjunctive therapy with either

The completion of the transaction involved AstraZeneca to acquire 100% of Pearl’s shares and provides access to PT003, a probable new treatment for chronic obstructive pulmonary disease (COPD),

The Breakthrough Therapy designation has been granted by the regulator, after vetting the results from the Phase II Study (DMD114117), submitted in April at Cold Spring Harbor. The

Opened with an aim to capitalize early-stage opportunities in healthcare segment, Johnson & Johnson Innovation center represents the third of four regional hubs being set up across the

Performed as part of the Ministry of Health’s routine evaluation, the audit confirmed the facility’s compliance with IMOH GMP requirements for the manufacture of medicinal products, the importation

The patent, to be issued on July 9, 2013, covers an injection system for methotrexate and subcutaneous administration of the drug for the treatment of rheumatoid arthritis and

Consisting of eight products initially, the portfolio is focused on hormones, pre- and post-natal nutrition and management of premenstrual syndrome (PMS). Mylan CEO Heather Bresch said women’s care

The agreement includes the purchase of API manufacturing business in the Netherlands with a satellite facility and sales office in the US, and an option to acquire a

Norethindrone Tablets USP, 0.35mg, are the generic version of Janssen Pharmaceuticals’ Micronor tablets, 0.35mg for 28-day cycle formulated to prevent pregnancy. The launch follows the US Food and